Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utility of Exosomal microRNAs to Predict Response to Androgen Deprivation Therapy in Prostate Cancer Patients

NCT02366494 is registered in ClinicalTrials.gov with Medical College of Wisconsin as lead sponsor.

NCT NCT02366494
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02366494 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utility of Exosomal microRNAs to Predict Response to Androgen Deprivation Therapy in Prostate Cancer Patients
Lead sponsor
Medical College of Wisconsin
Phase
Observational
Overall status
Completed
Start date
April 29, 2015
Completion date
May 11, 2021
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer